50 employees
Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases.
2003
$15M
from 4 investors over 4 rounds
SingVax Pte Ltd raised $15M on October 6, 2009
Investors: Phillip Private Equity, Charter Life Sciences, EDBI Pte Ltd and Venture Investors